The FY 2027 SNF Proposed Rule lands with a net 2.4% payment increase, but the real story is the $208 million in Value-Based Purchasing reductions that will offset gains for lower-performing facilities. Meanwhile, a new AJMC-published study confirms that interventional analytics platforms can cut SNF readmission rates by more than 15 percentage points — giving technology vendors the clinical evidence they've been waiting for.
Why it matters for vendors: The payment update creates a two-track market. Higher-performing facilities gain resources to invest in quality improvement and technology; lower-performing ones face financial pressure that makes them receptive to solutions that improve their VBP position. Analytics vendors now have peer-reviewed evidence that their platforms move the needle on the readmission metrics CMS cares most about.
Reimbursement
Regulatory
FY 2027 SNF Proposed Rule: 2.4% Payment Update Masks a Widening Gap Between High and Low Performers
What happened
CMS published the FY 2027 SNF Prospective Payment System proposed rule on April 2, proposing a net 2.4% increase in Medicare payment rates effective October 1, 2026. The update reflects a 3.2% market basket increase reduced by a 0.8% productivity adjustment, translating to an estimated $888 million in additional Medicare payments to skilled nursing facilities nationally. Comments are due June 1, 2026.
Why it matters
The headline number looks favorable, but the SNF Value-Based Purchasing program is estimated to redistribute approximately $208 million from lower-performing facilities to higher-performing ones in the same period. For facilities already struggling with quality metrics, the net payment increase will be substantially less than 2.4% — and for some, it may turn negative. This creates acute demand for quality improvement tools, compliance software, and consulting services that help facilities move up the VBP distribution. Vendors selling care coordination, quality reporting, and readmission prevention solutions should target the facilities most exposed to VBP reductions.
Rehinged analysis of 14,703 scored facilities shows 369 facilities with elevated penalty risk scores (70+), representing 2.5% of all SNFs nationally. These are the facilities most likely to see their FY 2027 payment gains eroded or eliminated by VBP reductions. Their average overall rating is just 1.3 stars — facilities that are already struggling operationally and financially. Another 5,850 facilities rated 1 or 2 stars face moderate penalty exposure and represent the next tier of demand for quality improvement solutions.
369
high penalty risk facilities
Facilities with highest penalty risk by state
The compound risk signal is striking: 25 facilities score in the top tier for both penalty risk and value-based incentive need, carrying an average rating of just 1.3 stars and averaging 139 beds each. These are mid-to-large facilities with overlapping financial exposure — they stand to lose the most under VBP redistribution while simultaneously being the most difficult to turn around. Among the broader set of 322 low-rated facilities with high penalty risk, the average readmission risk score is 52.8, suggesting these operators are also vulnerable to hospital readmission penalties. Vendors selling quality improvement platforms, readmission prevention tools, and compliance consulting should prioritize Illinois, California, and Texas, which together account for more than half of the highest-risk facilities nationally.
Watch for: The June 1 comment deadline for the proposed rule. Industry groups including AHCA and LeadingAge have signaled that the 2.4% increase is insufficient given rising labor and food costs. Watch for the final rule in late July or August, where CMS may adjust the productivity offset. Also monitor whether CMS expands the VBP program scope in the final rule — any expansion would amplify the penalty risk distribution mapped above.
Technology
Quality & Ratings
Peer-Reviewed Study: Interventional Analytics Platform Cuts SNF Readmissions by 15 Percentage Points
What happened
The American Journal of Managed Care published a retrospective analysis of 30-day risk-adjusted readmission rates across skilled nursing facilities from 2017 to 2022. Facilities using Real Time Medical Systems' interventional analytics platform showed readmission rates 15.2 percentage points lower than comparable SNFs, 12.3 points lower than Pennsylvania-wide averages, and 13.1 points lower than national averages. All comparisons were statistically significant at P < .0001.
Why it matters
This is the strongest peer-reviewed evidence yet that technology-based interventional analytics can meaningfully reduce SNF readmissions — the metric at the center of the Value-Based Purchasing program. With approximately 22% of the 1.7 million annual SNF admissions resulting in 30-day readmissions at a cost of $5.2 billion to Medicare, the financial case for analytics platforms has never been clearer. For vendors selling care coordination, real-time clinical surveillance, or predictive analytics to SNFs, this study provides the clinical validation that procurement committees require. For facility operators, the ROI argument now connects directly to VBP revenue retention.
Rehinged Intelligence analysis identifies 170 facilities with the highest readmission risk scores (70+) nationally, averaging just 2.8 stars overall. These represent the most acute targets for analytics-based readmission prevention solutions. Beyond the top tier, 13,465 facilities — more than 91% of all scored SNFs — show at least moderate readmission risk signals (score 40+), suggesting near-universal market opportunity for readmission-focused technology.
170
highest readmission risk
91%
with any readmission signal
2.8
avg stars (high-risk tier)
Highest readmission risk facilities by state
Among the 5,348 low-rated facilities (1-2 stars) with moderate-or-higher readmission risk, the average bed count is 114 — large enough to justify technology investments. These facilities are simultaneously the most likely to benefit from analytics platforms and the most financially motivated to adopt them, given their exposure to VBP reductions. The geographic distribution skews heavily toward the Southeast and Sun Belt. Vendors selling clinical analytics, real-time surveillance, or care transition platforms should target California, Georgia, Florida, and Texas first, where facility density and risk scores create the strongest per-territory ROI for sales teams.
Watch for: Whether CMS references this study or similar evidence in the FY 2027 final rule as justification for expanding VBP measures tied to readmissions. Also watch Real Time Medical Systems' commercial expansion — competitors will likely cite this study in their own sales materials, raising the bar for clinical evidence across the analytics category.